FDA approves standalone nasal spray for depression
Jan 22, 2025
CHARLOTTE, NC– A new nasal drug has been approved to treat depression. The drug Spravato  is a nasal spray made by Johnson and Johnson. It was first approved in 2019 with an oral antidepressant. Now the drug can be used on its own. The medication is related to ketamine — which can cause hallucinations and sedation. Because of its adverse side effects, it can only be administered by a healthcare provider.
https://www.wccbcharlotte.com/2025/01/22/fda-approves-standalone-nasal-spray-for-depression/
Respond, make new discussions, see other discussions and customize your news...

To add this website to your home screen:

1. Tap tutorialsPoint

2. Select 'Add to Home screen' or 'Install app'.

3. Follow the on-scrren instructions.

Feedback
FAQ
Privacy Policy
Terms of Service